Initial ICU exposure to IV hydromorphone increased 1-year persistent opioid use compared with fentanyl (16.5% vs 12.0%; aOR 1.25; 95% CI 1.00-1.56), particularly in those without prior use.
Cohort (n=14,197)
Yes
Does initiation of IV morphine or hydromorphone compared with fentanyl increase the risk of persistent opioid use in mechanically ventilated ICU patients?
Initial exposure to IV morphine or hydromorphone instead of fentanyl during mechanical ventilation in the ICU is associated with an increased risk of persistent opioid use one year after discharge in previously opioid-naive patients.
Odds Ratio: 1.25 (95% CI 1–1.56)
Absolute Event Rate: 16.5% vs 12%
Background Little is known about whether the choice of opioid influences long-term outcomes for critically ill patients. Research Question To determine whether initiation of IV morphine or hydromorphone during mechanical ventilation (MV) is associated with reduced opioid use after discharge relative to fentanyl. Study Design and Methods This was a retrospective cohort study of 14,197 veterans who underwent MV in 116 Veterans Administration hospitals (2014-2020) and who received fentanyl, morphine, or hydromorphone as the initial and only IV opioid during their first 2 days in the ICU. The primary outcome was persistent opioid use in the year after hospital discharge. Results Overall, 11,903 patients (83.8%) received fentanyl, 1,156 patients (8.1%) received morphine, and 1,138 patients (8.0%) received hydromorphone as the initial and only IV opioid during the first 2 days in the ICU. The median patient age was 67 years (interquartile range, 61-72 years). Persistent opioid use in the year after discharge was more common with hydromorphone (16.5%) vs fentanyl (12.0%; adjusted OR aOR, 1.25; 95% CI, 1.00-1.56), but not with morphine (15.7%) vs fentanyl (aOR, 1.12; 95% CI, 0.91-1.39). Stratified by prior persistent opioid use, the association between opioid initially received in the ICU and an increased risk of persistent use in the following year was present only among individuals without this history for both morphine and hydromorphine compared with fentanyl (morphine: aOR, 1.44 95% CI, 1.07-1.94; hydromorphone: aOR, 1.51 95% CI, 1.12-2.04). Interpretation Among patients in the ICU who received MV, persistent opioid use in the year after hospital discharge was more frequent among patients initially exposed to IV morphine or hydromorphone compared with fentanyl, but only among those without a prior history of persistent opioid use. The choice of initial opioid may have long-term consequences for patients. Further research is needed to confirm these exploratory findings.
Iwashyna et al. (Tue,) conducted a cohort in Mechanically ventilated in the ICU (n=14,197). IV hydromorphone or morphine vs. Fentanyl was evaluated on Persistent opioid use in the year after hospital discharge (aOR 1.25, 95% CI 1.00-1.56). Initial ICU exposure to IV hydromorphone increased 1-year persistent opioid use compared with fentanyl (16.5% vs 12.0%; aOR 1.25; 95% CI 1.00-1.56), particularly in those without prior use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: